A fibrinopeptide is a short peptide released from fibrinogen during its proteolytic conversion toward fibrin. The principal forms are Fibrinopeptide A and Fibrinopeptide B, cleaved from the amino-terminal regions of the A-alpha and B-beta chains, respectively. Their removal exposes molecular sites that promote fibrin assembly.[ref]
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin by D. L. Higgins and others. 1983, abstract: chain identity and thrombin-mediated peptide release
Experiments measured the release of the two fibrinopeptides separately and related their kinetics to fibrin polymerization. Under the tested solution conditions, release of Fibrinopeptide A preceded the main release of Fibrinopeptide B, with assembly affecting the later step.[ref]
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin by D. L. Higgins and others. Abstract: predominant pathway and polymerization-dependent release
The small released fragments and the remaining network-forming material have different roles. For a stipulated counting example, if each converted fibrinogen molecule releases two copies of one fibrinopeptide, converting 3 nmol generates 6 nmol of that fragment. The amount recovered can report the extent of cleavage; it does not by itself determine the final clot's stiffness or network geometry.
Fibrinopeptide B is the 14-amino acid peptide that thrombin releases from the N-terminus of each B-beta chain of human fibrinogen. Cleavage exposes the B knob on the remaining fibrin molecule, allowing a fibrin knob-hole interaction. Each fibrinogen molecule contains two B-beta chains and can therefore release two copies of Fibrinopeptide B.[ref]
Fibrinopeptides A and B release in the process of surface fibrin formation by Tomas Riedel and others. Introduction: twofold chain composition, 14-residue peptide and B-knob exposure
Its release need not track Fibrinopeptide A release identically. A study comparing dissolved and surface-adsorbed fibrinogen incubated the preparations with thrombin and measured the released peptides by high-performance liquid chromatography. Surface-bound preparations released Fibrinopeptide B without the characteristic solution-phase lag; densely adsorbed preparations could release more Fibrinopeptide B than Fibrinopeptide A.[ref]
Fibrinopeptides A and B release in the process of surface fibrin formation by Tomas Riedel and others. Methods: polystyrene wells and HPLC; Abstract and Figures4–5: altered lag and release proportions
The experiment shows why a measured fibrinopeptide ratio needs its reaction conditions. Molecular presentation at a surface changes access to cleavage sites, so a typical sequence observed in solution should not be turned into an unconditional rule for every preparation.
Fibrinopeptide A is the 16-amino acid peptide released from the N-terminus of each A-alpha chain of human fibrinogen by thrombin. Removing Fibrinopeptide A exposes the A knob on the remaining molecule, enabling a fibrin knob-hole interaction. The released fragment and the exposed binding site are different objects.[ref]
Fibrinopeptides A and B release in the process of surface fibrin formation by Tomas Riedel and others. Introduction: chain origin, peptide lengths and exposure of polymerization sites
Release of Fibrinopeptide A provides a measurable record of a particular peptide bond cleavage. A kinetic study measured Fibrinopeptide A and Fibrinopeptide B separately: under its solution conditions, at least 97% of Fibrinopeptide B release followed Fibrinopeptide A release. The study also found that a change at the cleavage-site arginine strongly reduced catalytic efficiency, linking amino acid identity to reaction rate.[ref]
Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin by D. L. Higgins and others. Abstract: sequential release and the Arg16-to-His variant
Articles by others on the same topic
There are currently no matching articles.